Gabriela Silva

Dr. Gabriela Silva

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ESElsa Seixas
Elsa Seixas
Raffaella GozzelinoRaffaella Gozzelino
Raffaella Gozzelino
ÂCÂngelo Chora
Ângelo Chora
AFAna Ferreira
Ana Ferreira
GSGabriela Silva
Gabriela Silva
MSMiguel P. Soares
Miguel P. Soares
Infection byPlasmodium, the causative agent of malaria, is associated with hemolysis and therefore with release of hemoglobin from RBC. Under inflammatory conditions, cell-free hemoglobin can be oxidized, releasing its heme prosthetic groups and producing deleterious free heme. Here we demonstrate that survival of aPlasmodium-infected host relies strictly on its ability to prevent the cytotoxic effects of free heme via the expression of the heme-catabolyzing enzyme heme oxygenase-1 (HO-1; encoded by theHmox1gene). When infected withPlasmodium chabaudi chabaudi(Pcc), wild-type (Hmox1+/+) BALB/c mice resolved infection and restored homeostasis thereafter (0% lethality). In contrast, HO-1 deficient (Hmox1−/−) BALB/c mice developed a lethal form of hepatic failure (100% lethality), similar to the one occurring inPcc-infected DBA/2 mice (75% lethality). Expression of HO-1 suppresses the pro-oxidant effects of free heme, preventing it from sensitizing hepatocytes to undergo TNF-mediated programmed cell death by apoptosis. This cytoprotective effect, which inhibits the development of hepatic failure inPcc-infected mice without interfering with pathogen burden, is mimicked by pharmacological antioxidants such as N-acetylcysteine (NAC). When administered therapeutically, i.e., afterPccinfection, NAC suppressed the development of hepatic failure inPcc-infected DBA/2 mice (0% lethality), without interfering with pathogen burden. In conclusion, we describe a mechanism of host defense againstPlasmodiuminfection, based on tissue cytoprotection against free heme and limiting disease severity irrespectively of parasite burden.

1 November 2000 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
MCMaria A. Carrondo
Maria A. Carrondo
CFCarlos Frazão
Carlos Frazão
GSGabriela Silva
Gabriela Silva
Cláudio M. GomesCláudio M. Gomes
Cláudio M. Gomes
PMPedro M Matias
Pedro M Matias
JGJean Le Gall
Jean Le Gall

1 December 2007 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MSMark P. Seldon
Mark P. Seldon
GSGabriela Silva
Gabriela Silva
NPNadja Pejanovic
Nadja Pejanovic
RLRasmus Larsen
Rasmus Larsen
IGIsabel Pombo Gregoire
Isabel Pombo Gregoire
MSMiguel P. Soares
Miguel P. Soares
Heme oxygenase-1 (HO-1; encoded by the Hmox1 gene) catalyzes the degradation of free heme into biliverdin, via a reaction that releases iron (Fe) and carbon monoxide. We report that HO-1 down-regulates the proinflammatory phenotype associated with endothelial cell (EC) activation by reducing intracellular nonprotein-bound Fe (labile Fe). EC isolated from Hmox1−/− mice have higher levels of intracellular labile Fe and reactive oxygen species (ROS) as compared with EC isolated from Hmox1+/+ mice. Basal and TNF-induced expression of VCAM-1, ICAM-1, and E-selectin were increased in Hmox1−/− vs Hmox1+/+ EC, an effect reversed by Fe chelation using deferoxamine mesylate (DFO). Fe chelation inhibits TNF-driven transcription of Vcam-1, Icam-1, and E-selectin, as assessed using luciferase reporter assays. This effect is associated with inhibition of the transcription factor NF-κB via a mechanism that is not associated with the inhibition of IκBα phosphorylation/degradation or NF-κB (i.e., RelA) nuclear translocation, although it affects very modestly NF-κB binding to DNA κB consensus sequences in the Vcam-1 and E-selectin promoters. HO-1 inhibits NF-κB (i.e., RelA) phosphorylation at Ser276, a phosphoacceptor that is critical to sustain TNF-driven NF-κB activity in EC. This effect was mimicked by Fe chelation as well as by antioxidants (N-acetylcysteine). In conclusion, we demonstrate a novel mechanism via which HO-1 down-modulates the proinflammatory phenotype of activated EC, i.e., the inhibition of RelA phosphorylation at Ser276.

1 October 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GSGabriela Silva
Gabriela Silva
VJViktoria Jeney
Viktoria Jeney
ÂCÂngelo Chora
Ângelo Chora
RLRasmus Larsen
Rasmus Larsen
JBJozsef Balla
Jozsef Balla
MSMiguel P. Soares
Miguel P. Soares
Several pathologic conditions are associated with hemolysis, i.e. release of ferrous (Fe(II)) hemoglobin from red blood cells. Oxidation of cell-free hemoglobin produces (Fe(III)) methemoglobin. More extensive oxidation produces (Fe(III)/Fe(IV)O) ferryl hemoglobin. Both cell-free methemoglobin and ferryl hemoglobin are thought to contribute to the pathogenesis of hemolytic disorders. We show hereby that ferryl hemoglobin, but not hemoglobin or methemoglobin, acts as a potent proinflammatory agonist that induces vascular endothelial cells in vitro to rearrange the actin cytoskeleton, forming intercellular gaps and disrupting the integrity of the endothelial cell monolayer. Furthermore, ferryl hemoglobin induces the expression of proinflammatory genes in endothelial cells in vitro, e.g. E-selectin, Icam-1, and Vcam-1, through the activation of the nuclear factor κB family of transcription factors. This proinflammatory effect, which requires actin polymerization, involves the activation of the c-Jun N-terminal kinase and the p38 mitogen-activated protein kinase signal transduction pathways. When administered to naïve mice, ferryl hemoglobin induces the recruitment of polymorphonuclear cells, demonstrating that it acts as a proinflammatory agonist in vivo. In conclusion, oxidized hemoglobin, i.e. ferryl hemoglobin, acts as a proinflammatory agonist that targets vascular endothelial cells.

1 September 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Cláudio M. GomesCláudio M. Gomes
Cláudio M. Gomes
GSGabriela Silva
Gabriela Silva
SOSolange Oliveira
Solange Oliveira
JLJean LeGall
Jean LeGall
MLMing-Yih Liu
Ming-Yih Liu
MTMiguel Teixeira
Miguel Teixeira
Rubredoxin-oxygen oxidoreductase (ROO) is the final component of a soluble electron transfer chain that couples NADH oxidation to oxygen consumption in the anaerobic sulfate reducerDesulfovibrio gigas. It is an 86-kDa homodimeric flavohemeprotein containing two FAD molecules, one mesoheme IX, and one Fe-uroporphyrin I per monomer, capable of fully reducing oxygen to water. EPR studies on the native enzyme reveal two components with g values at ∼2.46, 2.29, and 1.89, which are assigned to low spin hemes and are similar to the EPR features of P-450 hemes, suggesting that ROO hemes have a cysteinyl axial ligation. At pH 7.6, the flavin redox transitions occur at 0 ± 15 mV for the quinone/semiquinone couple and at −130 ± 15 mV for the semiquinone/hydroquinone couple; the hemes reduction potential is −350 ± 15 mV. Spectroscopic studies provided unequivocal evidence that the flavins are the electron acceptor centers from rubredoxin, and that their reduction proceed through an anionic semiquinone radical. The reaction with oxygen occurs in the flavin moiety. These data are strongly corroborated by the finding that rubredoxin and ROO are located in the same polycistronic unit of D. gigas genome. For the first time, a clear role for a rubredoxin in a sulfate-reducing bacterium is presented.

26 May 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
SHSiti-Fauziah Hendrayani
Siti-Fauziah Hendrayani
BABothaina Al-Harbi
Bothaina Al-Harbi
MAMysoon M. Al-Ansari
Mysoon M. Al-Ansari
GSGabriela Silva
Gabriela Silva
AAAbdelilah Aboussekhra
Abdelilah Aboussekhra
The inflammatory/cancer-related IL-6/STAT3/NF-B positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts